Journal of Cardiovascular Translational Research

Scope & Guideline

Bridging Innovation and Clinical Excellence in Cardiovascular Health

Introduction

Delve into the academic richness of Journal of Cardiovascular Translational Research with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN1937-5387
PublisherSPRINGER
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 2008 to 2024
AbbreviationJ CARDIOVASC TRANSL / J. Cardiovasc. Transl. Res.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressONE NEW YORK PLAZA, SUITE 4600 , NEW YORK, NY 10004, UNITED STATES

Aims and Scopes

The Journal of Cardiovascular Translational Research focuses on bridging the gap between basic cardiovascular research and clinical applications. The journal aims to publish innovative findings that contribute to the understanding, diagnosis, treatment, and prevention of cardiovascular diseases. It emphasizes translational research that moves discoveries from the laboratory to the bedside.
  1. Translational Research in Cardiovascular Medicine:
    The journal prioritizes studies that translate laboratory findings into clinical practice, enhancing understanding of cardiovascular pathophysiology and treatment.
  2. Innovative Therapeutic Strategies:
    Research on novel therapeutic approaches, including pharmacological interventions, surgical techniques, and device development, is a core focus.
  3. Biomarkers and Diagnostics:
    The journal explores the identification and validation of biomarkers for cardiovascular diseases, facilitating early diagnosis and personalized treatment.
  4. Advanced Imaging and Computational Modeling:
    Papers utilizing advanced imaging techniques and computational modeling to study cardiovascular function and disease progression are frequently published.
  5. Pathophysiology of Cardiovascular Diseases:
    The journal covers research on the underlying mechanisms of cardiovascular diseases, including genetic, metabolic, and inflammatory pathways.
  6. Patient-Centric Studies:
    Clinical trials and studies that assess patient outcomes, quality of life, and healthcare delivery related to cardiovascular conditions are emphasized.
Recent publications in the Journal of Cardiovascular Translational Research indicate several emerging themes and trends that are shaping the future of cardiovascular research. These areas reflect the evolving landscape of the field and the journal's commitment to addressing contemporary challenges in cardiovascular medicine.
  1. Extracellular Vesicles and Non-Coding RNAs:
    Research on the role of extracellular vesicles and non-coding RNAs in cardiovascular diseases is gaining traction, highlighting their potential as biomarkers and therapeutic targets.
  2. Machine Learning and Artificial Intelligence Applications:
    The integration of machine learning and AI in analyzing cardiovascular data is a rapidly growing area, facilitating improved diagnostic accuracy and patient management.
  3. Metabolic Reprogramming and Cardiovascular Health:
    Studies exploring metabolic pathways and their impact on cardiovascular diseases are increasingly relevant, linking metabolism with heart function and disease progression.
  4. Personalized Medicine and Genomics:
    There is a growing emphasis on personalized medicine approaches, utilizing genomic information to tailor treatments for individuals with cardiovascular diseases.
  5. Immunomodulation in Cardiovascular Therapy:
    Research focusing on the role of the immune system in cardiovascular health and disease is emerging, including studies on immunotherapies and inflammatory pathways.
  6. Digital Health Technologies:
    The application of digital health technologies, including telemedicine and wearable devices, is gaining prominence, reflecting the shift towards more patient-centered care.

Declining or Waning

While the Journal of Cardiovascular Translational Research has experienced growth in several areas, some themes appear to be declining in frequency or prominence. This section highlights those waning research areas that may reflect shifts in focus within the cardiovascular research community.
  1. Traditional Pharmacological Approaches:
    There appears to be a decline in studies focused solely on traditional pharmacological treatments, as the field shifts towards more integrated and innovative therapeutic strategies.
  2. Basic Animal Model Studies without Translational Relevance:
    Research that does not bridge basic science with clinical implications is becoming less common, with a preference for studies that demonstrate direct translational potential.
  3. Epidemiological Studies with Limited Clinical Application:
    While epidemiological research remains important, studies that do not connect findings to actionable clinical insights or therapeutic developments are less frequently published.
  4. Isolated Mechanistic Studies:
    There is a noticeable reduction in the publication of studies that focus exclusively on isolated mechanisms without a broader translational application to cardiovascular health or disease.

Similar Journals

Nature Reviews Cardiology

Pioneering Excellence in Cardiac Research and Clinical Practice
Publisher: NATURE PORTFOLIOISSN: 1759-5002Frequency: 12 issues/year

Nature Reviews Cardiology, published by NATURE PORTFOLIO, stands as a premier academic journal in the field of cardiology and cardiovascular medicine, boasting an impressive impact factor and a distinguished ranking of #1 out of 387 in Scopus. Since its inception in 2009, this exemplary journal has continuously delivered cutting-edge reviews and insights, supporting researchers, healthcare professionals, and students in navigating the complex landscape of cardiovascular health. With a commitment to providing open access and disseminating rigorous research, Nature Reviews Cardiology captures the forefront of innovation and scholarship, critical for facilitating advancements in cardiovascular science and clinical practice. Situated in the United Kingdom and with a vibrant global readership, this journal perpetuates academic excellence, ensuring accessibility to the latest findings that shape prevention, diagnosis, and treatment strategies in cardiology through to 2024 and beyond.

BASIC RESEARCH IN CARDIOLOGY

Leading the way in high-quality cardiovascular research.
Publisher: SPRINGER HEIDELBERGISSN: 0300-8428Frequency: 6 issues/year

BASIC RESEARCH IN CARDIOLOGY, published by SPRINGER HEIDELBERG, is an esteemed peer-reviewed journal dedicated to advancing the field of cardiology and cardiovascular medicine since 1973. With a strong emphasis on the latest breakthroughs in basic and translational research, this journal offers a platform for high-quality, impactful studies that contribute to our understanding of cardiac function and related physiological processes. Currently ranked in the Q1 category in Cardiology and Cardiovascular Medicine, as well as Physiology and Medical Physiology, BASIC RESEARCH IN CARDIOLOGY is recognized as a leading journal within these disciplines, boasting impressive Scopus ranks that place it in the top tiers of global research output. While it does not offer open access, its contributions are pivotal for researchers, clinicians, and students seeking to stay abreast of cutting-edge discoveries and methodologies in cardiovascular science. With its commitment to scholarly excellence, this journal plays a critical role in shaping the future of cardiac research and clinical practice.

VASCULAR MEDICINE

Pioneering insights in vascular medicine for a healthier tomorrow.
Publisher: SAGE PUBLICATIONS LTDISSN: 1358-863XFrequency: 6 issues/year

Vascular Medicine is a premier academic journal for researchers and practitioners in the field of cardiovascular health, published by SAGE Publications Ltd. With an ISSN of 1358-863X and E-ISSN 1477-0377, this esteemed journal has been at the forefront of publishing quality research since its inception in 1992, with convergence extending to 2024. Ranked in the Q2 category for both Cardiology and Cardiovascular Medicine as well as for miscellaneous Medicine in 2023, it is recognized for its significant contributions to advancing knowledge and clinical practice within these domains. Its Scopus ranking situates it at #91 out of 387 in the field, reflecting its high impact and the relevance of its published research, which is crucial for addressing the challenges in vascular health today. Although it is not an open-access journal, Vascular Medicine remains dedicated to disseminating vital findings that bridge the gap between research and clinical application, making it an essential resource for medical researchers, healthcare professionals, and students alike.

METABOLISM-CLINICAL AND EXPERIMENTAL

Driving Discovery in Clinical Metabolism and Health
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0026-0495Frequency: 12 issues/year

METABOLISM-CLINICAL AND EXPERIMENTAL is a premier academic journal published by W B SAUNDERS CO-ELSEVIER INC, with a distinguished history dating back to 1952. This journal serves as a vital repository of knowledge in the fields of Endocrinology, Diabetes, and Metabolism, consistently ranking in the top quartile (Q1) within these categories according to the latest metrics. With an impressive impact factor and recognized for its contributions to Biochemistry, Genetics, and Molecular Biology, it ranks #5 out of 128 in the Scopus database for Endocrinology and #11 out of 244 for Medicine related to Endocrinology, Diabetes, and Metabolism, placing it in the 95th and 96th percentiles, respectively. While the journal does not currently offer open access, it maintains rigorous peer review standards and publishes cutting-edge research that drives forward the understanding of metabolic diseases and clinical practices. By engaging with METABOLISM-CLINICAL AND EXPERIMENTAL, researchers, healthcare professionals, and students can explore groundbreaking advancements and pivotal findings that shape the future of metabolic health.

JOURNAL OF CLINICAL INVESTIGATION

Driving discovery and dialogue in clinical medicine.
Publisher: AMER SOC CLINICAL INVESTIGATION INCISSN: 0021-9738Frequency: 12 issues/year

JOURNAL OF CLINICAL INVESTIGATION is a premier scholarly journal published by the American Society for Clinical Investigation, dedicated to advancing the field of clinical research and medicine since its inception in 1945. With an impressive impact factor and ranked Q1 in the field of Medicine (miscellaneous), it stands out as a leading source of high-quality research, reflecting its exceptional position in Scopus ranking as #13 out of 636 in General Medicine, placing it in the 98th percentile. The journal focuses on groundbreaking studies that explore the underlying mechanisms of human disease, facilitating a deeper understanding that drives clinical practice and innovation. Although it is not an open-access journal, the insights and findings published in this esteemed journal are essential reading for researchers, healthcare professionals, and students aspiring to contribute to the dynamic landscape of clinical investigation. Published in the United States, it continues to shape the dialogue and advancement within the medical community through its rigorous peer-review process and commitment to excellence.

Cardiovascular Diagnosis and Therapy

Bridging Research and Practice in Cardiovascular Medicine
Publisher: AME PUBLISHING COMPANYISSN: 2223-3652Frequency: 6 issues/year

Cardiovascular Diagnosis and Therapy, an esteemed journal in the field of Cardiology and Cardiovascular Medicine, is published by AME PUBLISHING COMPANY, based in Hong Kong, China. With an ISSN of 2223-3652 and an E-ISSN of 2223-3660, this open-access journal aims to present cutting-edge research that significantly advances diagnostic and therapeutic practices in cardiovascular health. Recognized for its impact, it holds a 2023 category quartile ranking of Q2 and is positioned at rank #124 out of 387 in Scopus, reflecting its noteworthy contribution to medical literature with a percentile of 68th. The journal welcomes contributions that span various aspects of cardiovascular research, including clinical trials, epidemiological studies, and innovative therapeutic approaches, making it a vital resource for researchers, practitioners, and students alike, committed to improving cardiovascular care.

IJC Heart & Vasculature

Transforming Cardiovascular Care Through Open Research
Publisher: ELSEVIER IRELAND LTDISSN: Frequency: 4 issues/year

IJC Heart & Vasculature is a premier open-access journal published by Elsevier Ireland Ltd, dedicated to advancing research in the fields of cardiology and cardiovascular medicine. Since its inception in 2013, this journal has established itself as a valuable resource for clinicians, researchers, and students keen on exploring the latest developments in heart and vascular health. With an impressive impact factor and ranked within Q2 in its category (2023), IJC Heart & Vasculature has achieved a significant Scopus rank of #125 out of 387, placing it in the 67th percentile of cardiology journals. The journal not only emphasizes high-quality research but also promotes innovative studies that can shape clinical practices and improve patient outcomes. Researchers and professionals can access a plethora of peer-reviewed articles, original research, and comprehensive reviews that unravel the complexities of cardiovascular science. With a commitment to fostering open and impactful dialogue in the field, IJC Heart & Vasculature is poised to be an essential platform for knowledge exchange in the evolving landscape of cardiovascular research.

Cardiovascular Innovations and Applications

Empowering healthcare professionals with the latest cardiovascular innovations.
Publisher: COMPUSCRIPTISSN: 2009-8618Frequency: 1 issue/year

Cardiovascular Innovations and Applications is a premier open-access journal dedicated to advancing knowledge in the field of cardiovascular medicine. Published by COMPUSCRIPT since 2016, this journal provides a platform for the dissemination of innovative research and applications that address crucial topics in cardiology, aiming to bridge the gap between clinical practice and cutting-edge research. With an ISSN of 2009-8618 and an E-ISSN of 2009-8782, it operates on a global scale, facilitating access to high-quality content without financial barriers. The journal is positioned within the Medicine - Cardiology and Cardiovascular Medicine category, and its current Scopus rank of #321/387 reflects its potential for growth and influence in the academic community, being in the 17th percentile. Researchers, healthcare professionals, and students will find Cardiovascular Innovations and Applications an invaluable resource in their quest for the latest findings and advancements in cardiovascular health and treatment methodologies.

TRENDS IN CARDIOVASCULAR MEDICINE

Leading the Charge in Cardiovascular Innovation
Publisher: ELSEVIER SCIENCE LONDONISSN: 1050-1738Frequency: 8 issues/year

TRENDS IN CARDIOVASCULAR MEDICINE, published by Elsevier Science London, stands at the forefront of the cardiology field, with a commendable Q1 ranking in the category of Cardiology and Cardiovascular Medicine. Since its inception in 1991, this esteemed journal has provided a vital platform for disseminating cutting-edge research and innovative clinical practices, reflecting the dynamic developments in cardiovascular health. With an impact factor positioning it among the top 3% in its category, TRENDS IN CARDIOVASCULAR MEDICINE is essential reading for researchers, healthcare professionals, and students pursuing the latest advancements and evidence-based approaches in cardiology. Although this journal does not currently operate under an open-access model, its rich array of content encompasses a variety of topics from clinical studies to reviews, ensuring readers stay informed on the pivotal trends that shape cardiovascular medicine. This commitment to excellence underscores the journal's role as a premier resource for anyone dedicated to improving cardiovascular health.

Journal of the Practice of Cardiovascular Sciences

Shaping the Future of Cardiovascular Health Through Open Access
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 2395-5414Frequency: 3 issues/year

Journal of the Practice of Cardiovascular Sciences, published by Wolters Kluwer Medknow Publications, is an esteemed Open Access journal dedicated to advancing knowledge in the field of cardiovascular health. With its ISSN 2395-5414 and E-ISSN 2454-2830, the journal serves as a vital platform for researchers, healthcare professionals, and students to disseminate and access high-quality studies, innovations, and practical applications related to cardiovascular sciences. Established in 2015 as an Open Access journal, it promotes widespread sharing of insights to enhance cardiovascular practices and address contemporary challenges in the field. As part of a reputable publishing group, the journal is poised for growth and impact, contributing significantly to the ongoing dialogue in cardiovascular research and clinical practice.